Brief: Recordati Says FDA Grants Isturisa Expanded Indication
April 16 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI: FDA APPROVES INDICATION EXTENSION FOR ISTURISA INDICATION EXPANDS PREVIOUS FOR TREATMENT OF PATIENTS WITH CUSHING’S DISEASE Further company coverage: RECI.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Recordati Industria Chimica E Farmaceutica SpA
See all newsBrief: CVC Investor Enters Amendment To Allow Total Return Swap Derivatives In Context Of Takeover Bid On Recordati's Shares
Brief: Recordati Says Italy's Watchdog Consob Suspends Review Period For Approval Of Offer Document
Italy - Factors to watch on June 22
Brief: Respighi BidCo Files With Italy's Market Watchdog Consob Offer Document Related To Tender Offer For Recordati
Press Digest: Wall Street Journal - May 26